ClearPoint Neuro, Inc.
CLPT
$13.42
$0.151.13%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 31.04% | 36.34% | 29.33% | 24.86% | 16.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.04% | 36.34% | 29.33% | 24.86% | 16.56% |
| Cost of Revenue | 18.63% | 28.91% | 35.29% | 50.64% | 47.31% |
| Gross Profit | 40.46% | 41.69% | 25.62% | 10.63% | 0.61% |
| SG&A Expenses | 8.73% | 9.99% | 10.22% | 18.99% | 28.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.20% | 10.67% | 8.95% | 20.43% | 25.81% |
| Operating Income | 12.03% | 15.13% | 12.01% | -15.32% | -37.44% |
| Income Before Tax | 14.37% | 16.97% | 13.69% | -14.05% | -34.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.37% | 16.97% | 13.69% | -14.05% | -34.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.37% | 16.97% | 13.69% | -14.05% | -34.40% |
| EBIT | 12.03% | 15.13% | 12.01% | -15.32% | -37.44% |
| EBITDA | 14.00% | 17.57% | 14.49% | -13.03% | -35.63% |
| EPS Basic | 22.16% | 22.23% | 16.75% | -12.39% | -32.08% |
| Normalized Basic EPS | 22.15% | 22.23% | 16.75% | -12.40% | -32.09% |
| EPS Diluted | 22.16% | 22.23% | 16.75% | -12.39% | -32.08% |
| Normalized Diluted EPS | 22.15% | 22.23% | 16.75% | -12.40% | -32.09% |
| Average Basic Shares Outstanding | 9.84% | 6.90% | 4.03% | 1.71% | 1.76% |
| Average Diluted Shares Outstanding | 9.84% | 6.90% | 4.03% | 1.71% | 1.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
